MindMaze Therapeutics Holding SA
MMTZF- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001854078
No open-market purchases or sales by MindMaze Therapeutics Holding SA insiders were filed in the last 90 days; 1 institution reported holding it in 13F filings for Q2 2026, worth $19 in total; no superinvestor holds it.
Other share classesRLFTY
Q2 2023 vs. Q1 2023
How the institutions holding MindMaze Therapeutics Holding SA changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 0 | 3 | +3 |
| Shares | 0 | 504 | +504 |
| Value | $0 | $1.57K | +$1.57K |
New holders (3)
Institutions that held MindMaze Therapeutics Holding SA at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Ancora Advisors, LLC | 375 | $1.16K | 0.00% |
| Cornerstone Planning Group LLC | 117 | $364 | 0.00% |
| Strategic Investment Solutions, Inc. | 12 | $50 | 0.00% |
Sold out (0)
Institutions that held MindMaze Therapeutics Holding SA at the end of Q1 2023 and filed for Q2 2023 without it.
None.